Form D · Biotechnology
GB SCIENCES INC
Las Vegas, NV · CIK 0001165320
Offering snapshot reported Aug 2, 2023 · SEC filing
- Reported sold
- $75K Offering amount: $1M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $10K Reported outside-investor minimum
- First sale
- Jun 30, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 2, 2023 | Initial | $75,000 | No comparison | 2 | SEC filing |
| Jun 3, 2022 | Initial | $25,000 | No comparison | 1 | SEC filing |
| Oct 24, 2019 | Initial | $240,000 | No comparison | 1 | SEC filing |
| Oct 10, 2019 | Initial | $2,000,000 | No comparison | 21 | SEC filing |
| Oct 10, 2019 | Initial | $2,931,970 | No comparison | 17 | SEC filing |
| Oct 10, 2019 | Initial | $7,200,000 | No comparison | 60 | SEC filing |
| Oct 24, 2018 | Initial | $5,000,000 | No comparison | 28 | SEC filing |
| Nov 28, 2017 | Initial | $3,895,000 | No comparison | 48 | SEC filing |
| Jan 13, 2016 | Initial | $20,000 | No comparison | 2 | SEC filing |
| Jun 5, 2014 | Initial | $2,000,000 | No comparison | 1 | SEC filing |
| Apr 1, 2014 | Initial | $1,500,000 | No comparison | 10 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $100K
- Finders' fees
- $0
- Form D file number
- 021-488608
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Network 1 Financial Services, Inc. | 13577 |
Source: Form D, filed Aug 2, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Leslie Bocskor | Director |
| Edmond De Frank | Director |
| Craig Ellins | Director, Executive |
| Ksenia Griswold | Executive |
| Krin Ellery Kuethe | Executive |
| John Poss | Director, Executive |
| Andrea Small Howard | Director, Executive |
| Zach Swarts | Executive |
| Shane Terry | Director |
| Steven Weldon | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
9205 W. Russell Road Suite 240
Las Vegas, NV, 89148
Las Vegas, NV, 89148